期刊文献+

吡格列酮对大鼠脑出血后AQP4表达的影响 被引量:1

EFFECTS OF PIOGLITAZONE ON LEVEL OF AQUAPORIN-4 IN RATS AFTER INTRACEREBRAL HEMORRHAGE
下载PDF
导出
摘要 目的探讨吡格列酮对大鼠脑出血后脑组织水通道蛋白4(AQP4)表达的影响。方法将40只成年雄性Wistar大鼠随机分为假手术组、脑出血组、吡格列酮组。应用自体血尾状核定位注射方法建立大鼠自体血脑出血模型,分别采用免疫组化及半定量逆转录聚合酶链反应方法,检测脑组织AQP4蛋白及mRNA的表达。结果脑出血组AQP4蛋白的表达较假手术组明显升高(F=222.03,q=29.15,P<0.05),而吡格列酮组AQP4蛋白的表达较脑出血组明显降低(q=9.21,P<0.05)。脑出血组AQP4mRNA含量较假手术组明显增高(F=327.22,q=33.13,P<0.05);吡格列酮组AQP4mRNA含量与脑出血组比较明显降低(q=3.98,P<0.05)。结论吡格列酮能够抑制脑出血后血肿周围脑组织AQP4的表达,从而减轻脑水肿。 Objective To study the effects of pioglitazone on aquaporin-4 (AQP4) in rats after intracerebral hemorrhage. Methods Fourty adult male Wistar rats were randomly divided into sham-operated group, intracerebral hemorrhage model group ( model group) and pioglitazone group. Models of cerebral hemorrhage were created. Immunohistochemistry and RT PCR were used to detect the expressions of AQP4 and mRNA in the brain tissues. Results The expression of AQP4 protein in the model group was higher than that in the sham operated group (F=222.03,q=29.15,P〈0.05), and that in the pioglitazone group was lower than that in the model group (q=9.21 ,P〈0.05). Compared with the model group, the level of AQP4 mRNA in the sham-operated group (F=327.22,q=33.13,P〈0.05), and that in pioglitazone group were lower (q=3.98,P〈0.05). Conclusion Pioglita zone can inhibit the expression of AQP4 in brain tissue surrounding hematoma after cerebral hemorrhage, and suppress the expres- sion of AQP4 resulting in relief of brain edema.
出处 《青岛大学医学院学报》 CAS 2013年第3期227-229,233,共4页 Acta Academiae Medicinae Qingdao Universitatis
关键词 吡格列酮 脑出血 水通道蛋白4 大鼠 Wistar pioglitazone intracerebral hemorrhage aquaporin 4 rats, Wistar
  • 相关文献

参考文献18

  • 1李燕华,孙善全.实验性脑出血后水通道蛋白-4的表达变化[J].中华神经科杂志,2004,37(2):144-148. 被引量:55
  • 2PARK S W, YIJ H, MIRANPURI G, et al. Thiazolidinedi?one class of peroxisome proliferator-activated receptor gamma agonises prevents neuronal damage, motor dysfunction, mye?lin loss, neuropathtic pain, and inflammation after spinal cord injury in adult rats[J].J Pharmacol Exp Ther , 2007,320(3): 1002-1012.
  • 3LUO v: YIN W, SIGNORE A r. et al. Neuroprotection against focal ischemic brain injury by the peroxisome prolifera?tor-activated receptor-gamma agonist rosiglitazone[IJ.J Neu?rochern , 2006,97(2) :435-448.
  • 4张婧媛,张艳桥,张一娜,裴丽春,徐长庆,杨微.PPAR-γ激动剂减轻缺氧性大鼠神经细胞损伤的作用机制[J].中国病理生理杂志,2009,25(1):89-92. 被引量:8
  • 5YANG G v, BETZ A L, CHENERERT T L, et al. Experi?mental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rat[J].J Neurosury, 1994,81(1) :93-102.
  • 6ZHOU X M, MARC R, BIGIO D. Intracerebral injection of autologous whole blood in rat: time course of inflammation and cell death[J]. Neuroscience Letters, 2000,283 (3): 230- 232.
  • 7STEINER T, BOSELJ. Options to restrict hematoma expan?sion after spontaneous intracerebral hemorrhage[J]. Stroke, 2010,41(2): 402-409.
  • 8唐伦先,冯刚,蒋健.AQP水通道蛋白和脑水肿[J].中国急救医学,2004,24(7):506-507. 被引量:5
  • 9WANG G H,JIANG Z L, LI Y C, et al. Free-radical scaven?ger edaravone treatment confers neuroprotection against trau?matic brain injury in rats[J].J Neurotraurna , 2011,28:2123- 2134.
  • 10MEDICI V, FRASSONI C, TASSI L, et al. Aquaporin 4 ex?pression in control and epileptic human cerebral cortex[J]. Brain Res, 2011,1367: 330-339.

二级参考文献55

共引文献73

同被引文献12

  • 1BEDERSON J B, PITTS L H, TSUJI M, et al. Rat middle cerebral artery occlusion:evaluation of the model and develop- ment of a neurologic examination[J]. Stroke, 1986,17: 472- 476.
  • 2GU Z, JIANG Q, ZHANG G. c Jun N-terminal kinase activa tion in hippocampal CA1 region was involved in ischemic injury [J]. Neuroreport, 2001,12 : 897-900.
  • 3MING L, ZHAO F F, TANG J J, et al. The neuroproteetion of hydrogen sulfide against MPTP-induced dopaminergic neu- ron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels[Jl. ANTIOXIDANTS &- REDOX SIGNALING, 2012,17(6) :849-859.
  • 4JAVADOV S, HUNTER J C,BABRETO T G, et al. Targe- ting the mitoehondrial permeaability transition: cardiac ische- mia reperfusion versus carcinogenesis[J]. Cell Physiol Bio- chem, 2011,27(3/4) :179-190.
  • 5YUAN X, XIE N C,XIE A C, et al. Role of PIaK/Akt in di- azoxide preconditioning against rat hippocampal neuronal death in pilocarpine-induced seizures [- J]. Brain Research, 2011, 1383:135- 140.
  • 6GONZALES N R, SHAH J, SANGHA N, et al. Design of a prospective, dose-escalation study evaluating the Safety of Pio glitazone for Hematoma Resolution in Intracerebral Hem-or- rhage (SHRINC)[-J]. Int J Stroke, 2013,8(5):388-396.
  • 7ZHANG H L, XU M, WEI C, et ah Neurooprotective effects of pioglitizone in a rat model of permanent focal cerebral ische- mia are associated with peroxisome proliferator-activated re ceptor gamma-mediated suppression of nuclear factor kB sig- naling pathway[J]. Neuroscience, 2011,176 : 381-395.
  • 8TUREYEN K, KAPADIA R. BOWEN KK, et al. Peroxisome proliferators-activated receptor gamma agonists induce neuro- protection following transient focal isehemia in normotensive normaglycemic as well as hypertensive and type-2 diabetic ro- dents[J]. J Neurochem, 2007,101(1):41-56.
  • 9RAMYA K, JAE-HYUK Y. Mechanisms of anti-inflammato- ry and neuroprotective actions of PPAR gamma agonists[J]. Front Biosci, 2008,13 : 1813-1826.
  • 10张云,刘斌.脑出血后继发性脑损伤的细胞凋亡机制研究进展[J].中国康复医学杂志,2007,22(12):1130-1133. 被引量:17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部